Matinas BioPharma Holdings (MTNB) Revenue (2015 - 2023)
Matinas BioPharma Holdings (MTNB) reported Revenue of $721000.0 for Q2 2023, down 32.17% year-over-year from $1.1 million in Q2 2022, and up 92.27% quarter-over-quarter from $375000.0 in Q1 2023.
Matinas BioPharma Holdings (MTNB) Revenue (2015 - 2023) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has 8 years of Revenue data on file, last reported at $721000.0 in Q2 2023.
- Revenue for Q2 2023 came in at $721000.0, down 32.17% year-over-year; the trailing twelve-month figure through Dec 2023 was $1.1 million (down 65.63% YoY), and the FY2023 annual result was $1.1 million, down 65.62% from the prior year.
- Revenue improved to $721000.0 in Q2 2023 per MTNB's latest filing, from $375000.0 in the prior quarter.
- Over five years, Revenue peaked at $1.1 million in Q2 2022 and troughed at -$62833.0 in Q4 2020.
- A 5-year average of $444081.2 and a median of $235416.5 in 2020 frame the typical range for Revenue.
- The sharpest annual moves came in 2022 and 2023: Revenue jumped 319319.22% in 2022, then sank 32.17% in 2023.
- A 5-year view of Revenue shows it stood at $89812.0 in 2019, then plunged by 169.96% to -$62833.0 in 2020, then jumped by 99.47% to -$333.0 in 2021, then jumped by 319319.22% to $1.1 million in 2022, then slumped by 32.17% to $721000.0 in 2023.
- Business Quant data shows MTNB's Revenue at $721000.0 in Q2 2023, $375000.0 in Q1 2023, and $1.1 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 721,000.00 |
| Mar 31, 2023 | 375,000.00 |
| Dec 31, 2022 | 1.06 Mn |
| Sep 30, 2022 | 1.06 Mn |
| Jun 30, 2022 | 1.06 Mn |
| Dec 31, 2021 | -333.00 |
| Mar 31, 2021 | 33,333.00 |
| Dec 31, 2020 | -62,833.00 |
| Sep 30, 2020 | 95,833.00 |
| Jun 30, 2019 | 89,812.00 |
| Jun 30, 2018 | 89,813.00 |
| Mar 31, 2018 | 29,937.00 |
| Dec 31, 2017 | 44,906.00 |
| Sep 30, 2017 | 44,906.00 |
| Jun 30, 2017 | 44,906.00 |
| Mar 31, 2017 | 14,969.00 |
| Sep 30, 2015 | 59,858.00 |
| Jun 30, 2015 | 77,000.00 |
| Mar 31, 2015 | 57,636.00 |